Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Slade

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
British Heart Journal|July 1, 1993
Proarrhythmic effect of adenosine in a patient with atrial flutterA K Slade, C J Garratt
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1996
Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathyA K Slade, A J Camm
European Heart Journal|September 1, 1993
The arrhythmogenic substrate--diagnostic and therapeutic implications: hypertrophic cardiomyopathyA K Slade, R C Saumarez, W J McKenna
British Heart Journal|June 1, 1990
Pseudoxanthoma elasticum presenting with myocardial infarctionA K Slade, R M John, R H Swanton
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1992
Arrhythmia and hypertrophic cardiomyopathyC F Shakespeare, P J Keeling, A K Slade, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1994
New algorithms to increase the initial rate response in a minute volume rate adaptive pacemakerA K Slade, S Pee, S Jones, et al.
Journal of the American College of Cardiology|August 1, 1995
Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy?L Fei, A K Slade, K Prasad, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1994
Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodaroneL Fei, A K Slade, A A Grace, et al.
The American Journal of Cardiology|July 1, 1993
Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmiasP J Keeling, P Kulakowski, G Yi, et al.
Journal of the American College of Cardiology|May 1, 1995
Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humansF D Murgatroyd, A K Slade, S M Sopher, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
British Heart Journal|July 1, 1993
Proarrhythmic effect of adenosine in a patient with atrial flutterA K Slade, C J Garratt
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1996
Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathyA K Slade, A J Camm
European Heart Journal|September 1, 1993
The arrhythmogenic substrate--diagnostic and therapeutic implications: hypertrophic cardiomyopathyA K Slade, R C Saumarez, W J McKenna
British Heart Journal|June 1, 1990
Pseudoxanthoma elasticum presenting with myocardial infarctionA K Slade, R M John, R H Swanton
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1992
Arrhythmia and hypertrophic cardiomyopathyC F Shakespeare, P J Keeling, A K Slade, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1994
New algorithms to increase the initial rate response in a minute volume rate adaptive pacemakerA K Slade, S Pee, S Jones, et al.
Journal of the American College of Cardiology|August 1, 1995
Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy?L Fei, A K Slade, K Prasad, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1994
Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodaroneL Fei, A K Slade, A A Grace, et al.
The American Journal of Cardiology|July 1, 1993
Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmiasP J Keeling, P Kulakowski, G Yi, et al.
Journal of the American College of Cardiology|May 1, 1995
Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humansF D Murgatroyd, A K Slade, S M Sopher, et al.
Pageof 2